Of the tracked stories, 2 of 2 also mention Donald Trump, the most common co-covered peer. The 17-day window averages about 0.8 stories each week. At 6, the average consequence score sits above the same-window beat average of 5.5. health-it accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Erica Schwartz
Of the tracked stories, 2 of 2 also mention Donald Trump, the most common co-covered peer. The 17-day window averages about 0.8 stories each week. At 6, the average consequence score sits above the same-window beat average of 5.5. health-it accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window. This profile follows 2 Healthcare stories mentioning Erica Schwartz across the period from August 3, 2026 to August 19, 2026.
Stories tracked
2
Per week
0.8
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 209 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Erica Schwartz. Shared-story counts are live from our verified record — not editorial picks.
A White House health-policy aide with a hand in the childhood vaccine-schedule rewrite is tapped to run the FDA during a multistate cyclospora outbreak. Health systems and public-health officials now weigh the operational impact of leadership churn and a nominee whose recommendations physicians say lack scientific support.
The CDC faces a pivotal leadership moment with Dr. Erica Schwartz’s nomination amid a 25% staff loss and political tensions. Her confirmation could shape the agency’s capacity to control outbreaks and restore scientific credibility.